A preliminary new study recognized a possible link involving semaglutide along with a exceptional eye ailment that causes blindness.Eli Lilly introduced a different application that should offer some consumers with one-dose vials of Zepbound in a fifty% price cut, earning the weight loss medication additional economical and accessible.“Could the